Literature DB >> 4092001

Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia.

M W Teunissen, G J Bruining, B M De Jongh, E W Tenkate-Westerhof, D D Breimer.   

Abstract

Antipyrine salivary clearance and half-life and the rate of formation of three principal metabolites of antipyrine (4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine) were assessed in nine children with congenital adrenal hyperplasia, six of whom were salt-losers and three of whom were non-salt-losers. No differences were found in comparison with data obtained in normal children.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4092001      PMCID: PMC1400822          DOI: 10.1111/j.1365-2125.1985.tb05134.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

Review 1.  Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.

Authors:  J R Idle; R L Smith
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

Review 2.  Multiplicity of mammalian microsomal cytochromes P-45.

Authors:  A Y Lu; S B West
Journal:  Pharmacol Rev       Date:  1979-12       Impact factor: 25.468

Review 3.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

4.  Differential effects of enzyme induction on antipyrine metabolite formation.

Authors:  M Danhof; R M Verbeek; C J van Boxtel; J K Boeijinga; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

5.  Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.

Authors:  M Danhof; J R Idle; M W Teunissen; T P Sloan; D D Breimer; R L Smith
Journal:  Pharmacology       Date:  1981       Impact factor: 2.547

6.  Steroid hydroxylations by human adrenal cortex microsomes 1, 2.

Authors:  E B Nelson; G T Bryan
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

7.  Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.

Authors:  N Buchanan; M Davis; M Danhof; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

8.  Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.

Authors:  M W Teunissen; P Spoelstra; C W Koch; B Weeda; W van Duyn; A R Janssens; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

9.  Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency).

Authors:  B Dupont; S E Oberfield; E M Smithwick; T D Lee; L S Levine
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

10.  Effects of growth hormone on antipyrine kinetics in children.

Authors:  A B Rifkind; P Saenger; L S Levine; J Pareira; M I New
Journal:  Clin Pharmacol Ther       Date:  1981-07       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.